$ZVIA

Zevia PBC (ZVIA): Results of Operations and Financial Condition

Zevia PBC (ZVIA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_974482.htm EXHIBIT 99.1 ex_974482.htm Exhibit 99.1 Zevia Announces Second Quarter 2026 Results Net Sales at the High End of Outlook; Adjusted EBITDA Exceeds Outlook LOS ANGELES – August 5, 2026 (BUSINESS WIRE) – Zevia PBC (“Zevia” or the “Company”) (NYSE: ZVIA), the

Original reporting
Published Aug 5, 2026, 8:06 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 8:17 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$ZVIA
Neutral
high confidence
Mentioned
$ZVIA
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ZVIANeutralHigh
01

Why it matters

Traders can update models using the provided Q2 performance metrics and the explicit FY2026 and Q3 2026 guidance ranges for net sales and adjusted EBITDA loss.

02

Market read

The release combines a sales and margin update with forward guidance, making it a direct catalyst for near-term positioning in ZVIA.

03

What to watch

Equity-based compensation rose to $2.1M, and restructuring/productivity initiatives drove costs; both can distort GAAP vs adjusted trends and affect forward expectations.

Relevance 7/10Novelty 9/10Timing: after-hours today, ahead of the 4:30 p.m. ET conference call

Background

This is Zevia’s SEC 8-K filing for Q2 2026 results (Item 2.02) with an attached earnings release and 2026 outlook.

Company-level read

Ticker impact

$ZVIANeutralHigh confidence
Context

Zevia reported Q2 net sales of $45.0M, improved gross margin to 48.9%, and guided FY2026 net sales to $170M-$175M with adjusted EBITDA loss of $2.0M-$4.0M.

Expected impact

Likely modest volatility around the release and call, driven by whether investors focus on sales growth at the high end of outlook versus continued adjusted EBITDA losses.

Evidence & confidence

The filing includes specific Q2 datapoints (sales, margin, net loss, adjusted EBITDA) and explicit FY and Q3 guidance ranges, which are direct inputs to valuation and positioning.

Market effects

Signals ongoing cost discipline and pricing-led revenue support for zero-sugar beverage brands, but highlights margin sensitivity to aluminum and freight.

No specific regional demand signal beyond company-wide financials.

Limited, as the disclosure is company-specific with no stated international regulatory or macro shock.

Counterpoint

Investors may discount the gross margin improvement if volume softness (down 3.7%) persists, implying pricing is masking demand weakness.

Key entities

  • Zevia PBC

    Reports Q2 2026 results and provides FY2026 and Q3 2026 guidance in the 8-K earnings release.

  • Alexandre Ruberti

    CEO quoted on strategic priorities and momentum in 2026.

  • Girish Satya

    CFO quoted on outlook and disciplined execution.

  • Cardi B brand endorsement agreement

    Mentioned as the driver of higher equity awards in Q2.

Related articles

$ZVIAMedAI 8/10

Zevia Appoints Brian Bousley as Chief Commercial Officer

Zevia PBC (NYSE: ZVIA) appointed Brian Bousley as Executive Vice President and Chief Commercial Officer, effective immediately. He will lead sales, distribution and category management, reporting to CEO Amy Taylor. Zevia said Bousley brings 25+ years in beverages, including CCO roles at Yerba Madre and prior leadership at Pabst Brewing and Red Bull.

$HMNMed

Horace Mann Educators Q2 Earnings Call Highlights

Horace Mann (NYSE:HMN) reported Q2 call highlights. Management said auto frequency and severity trends were favorable and liability losses mid-single digits. It cut its full-year catastrophe-loss assumption to about $75M from $90M, while lowering total net investment income outlook to $465M-$475M. Revenue rose 8% YoY; life sales +20%.

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.